SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-16-026500
Filing Date
2016-10-28
Accepted
2016-10-28 16:16:31
Documents
54
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q sbph-10q_20160930.htm 10-Q 1524464
2 EX-31.1 sbph-ex311_8.htm EX-31.1 16866
3 EX-31.2 sbph-ex312_6.htm EX-31.2 16379
4 EX-32.1 sbph-ex321_7.htm EX-32.1 11510
  Complete submission text file 0001564590-16-026500.txt   5014827

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT sbph-20160930.xml EX-101.INS 936070
6 XBRL TAXONOMY EXTENSION SCHEMA sbph-20160930.xsd EX-101.SCH 35786
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE sbph-20160930_cal.xml EX-101.CAL 32693
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE sbph-20160930_def.xml EX-101.DEF 144472
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE sbph-20160930_lab.xml EX-101.LAB 289244
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sbph-20160930_pre.xml EX-101.PRE 236043
Mailing Address 86 SOUTH STREET HOPKINTON MA 01748
Business Address 86 SOUTH STREET HOPKINTON MA 01748 508-473-5993 X119
Spring Bank Pharmaceuticals, Inc. (Filer) CIK: 0001566373 (see all company filings)

IRS No.: 522386345 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37718 | Film No.: 161958782
SIC: 2834 Pharmaceutical Preparations